LeadershipBoard of Directors:Douglas A. Berthiaume Joshua Bekenstein Dr. Michael J. Berendt Edward Conard Dr. Laurie H. Glimcher William Miller Thomas P. Salice Douglas A. Berthiaume, 59, has served as Chairman of the Board of Directors of the Company since February 1996 and has served as Chief Executive Officer and a Director of the Company since August 1994. Mr. Berthiaume also served as President of the Company from August 1994 to January 2002. In March 2003, Mr. Berthiaume once again became President of the Company. From 1990 to 1994, Mr. Berthiaume served as President of the Waters Chromatography Division of Millipore. Mr. Berthiaume is the Chairman of the Children’s Hospital Trust Board, a Trustee of the Children’s Hospital Medical Center and The University of Massachusetts Amherst Foundation and a Director of Genzyme Corporation. Mr. Bekenstein, 48, has served as a Diretor of the Company since 1994. He is a Managing Director of Bain Capital, LLC where he has worked since its inception in 1984. Mr. Bekenstein is a Director of Bombardier Recreational Products, Inc., Toys R Us, Bright Horizons Family Solutions, Inc., and Dollarama. Dr. Berendt, Ph.D., 58, has served as a Director of the Company since March 1998. Dr. Berendt is the President and Chief Executive Officer of Aegera Therapeutics, Inc., a position he assumed in March 2006. From August 2004 to March 2006, Dr. Berendt served as a Managing Director of Research Corporation Technologies. From November 2000 to August 2004, Dr. Berendt served as Managing Director, Life Sciences Group, AEA Investors Inc. Prior to joining AEA, Dr. Berendt worked for 18 years in the pharmaceutical industry where he served in a number of senior management positions including Senior Vice President of Research for the Pharmaceutical Division of Bayer Corporation and as Group Director of Drug Discovery at Pfizer, Inc. where he was responsible for immunology, pulmonary, inflammation, and antibiotic research. Dr. Berendt has served as a member of the Board of Directors of Myriad Genetics, Inc. and Onyx Pharmaceuticals, Inc., Catalyst Biosciences and Northstar Neuroscience. Mr. Conard, 50, has served as a Director of the Company since August 1994. He has been a Managing Director of Bain Capital, LLC since March 1993. Mr. Conard was previously a Director of Wasserstein Perella, an investment banking firm that specializes in mergers and acquisitions, and a Vice President of Bain & Company heading up the firm’s operations practice area. Mr. Conard is a Director of Innophos, Inc., Unisource Worldwide, Inc., Broder Brothers and Sensata Technologies, Inc. Dr. Glimcher, M.D., 55, has served as a Director of the Company since January 1998. She is the Irene Heinz Given Professor of Immunology at the Harvard School of Public Health and a Professor of Medicine at Harvard Medical School, positions She has held since 1991. Dr. Glimcher received her B.A. degree from Radcliffe College and her M.D. from Harvard Medical School. She is a Fellow of the American Academy of Arts and Sciences, a member of the Institutes of Medicine of the National Academy of Sciences and a member of the National Academy of Sciences. Dr. Glimcher is a Director of the Bristol-Myers Squibb Company. Mr. Kuebler, 53, has served as a Director of the Company since May, 2006. Mr. Kuebler served as Chairman and Chief Executive Officer of Covance, Inc., and its precursor companies from November 1994 to December 2004. He served as Chairman during 2005. Prior to joining Covance, Mr. Kuebler spent nearly 20 years in the pharmaceutical industry, at Abbot Laboratories, Squibb Inc. and Monsanto Health Care. Mr. Kuebler is currently a Director of Nektar Therapeutics and The Ocean Conservancy. Mr. Miller, 61, has served as a Director of the Company since January 1998. Mr. Miller is an independent director and investor. Most recently, from April 1996 to November 1999, He was Chairman and Chief Executive Officer of Avid Corporation. From March 1992 to September 1995, Mr. Miller served in several senior executive roles at Quantum Corporation including Chairman and Chief Executive Officer. He is a member of the Board of Directors of NVidia Corporation, Viewsonic Corporation, Digimarc Corporation and Overland Storage, Inc.
Mr. Salice, 47, has served as a Director of the Company since August 1994. Mr. Salice is a Managing Member of SFW Capital Partners, LLC, a position he assumed in January 2005. From June 1989 to December 2004, Mr. Salice served in a variety of capacities with AEA Investors, Inc., including Managing Director, President and Chief Executive Officer and Vice-Chairman. Mr. Salice is a member of the Board of Directors of Mettler-Toledo International Inc., and Agere Systems, Inc., and is a Trustee of Fordham University. On February 24, 2004, the Board elected Mr. Salice as it's Lead Director. EXECUTIVE OFFICERS OF THE REGISTRANTOfficers of the Company are elected annually by the Board of Directors and hold office at the discretion of the Board of Directors. The following persons serve as executive officers of the Company: Douglas A. Berthiaume Arthur G. Caputo Elizabeth Rae John Ornell Mark Beaudouin Terrence P. Kelly Douglas A. Berthiaume, 59, has served as Chairman of the Board of Directors of the Company since February 1996 and has served as Chief Executive Officer and a Director of the Company since August 1994. Mr. Berthiaume also served as President of the Company from August 1994 to January 2002. In March 2003, Mr. Berthiaume once again became President of the Company. From 1990 to 1994, Mr. Berthiaume served as President of the Waters Chromatography Division of Millipore. Mr. Berthiaume is the Chairman of the Children’s Hospital Trust Board, a Trustee of the Children’s Hospital Medical Center and The University of Massachusetts Amherst Foundation and a Director of Genzyme Corporation. Arthur G. Caputo, 56, became an Executive Vice President in March 2003 and has served as President of the Waters Division since January 2002. Previously, he was the Senior Vice President, Worldwide Sales and Marketing of the Company since August 1994. He joined Millipore in October 1977 and held a number of positions in sales. Previous roles include Senior Vice President and General Manager of Millipore’s North American Business Operations responsible for establishing the Millipore North American Sales Subsidiary and General Manager of Waters’ North American field sales, support and marketing functions. Elizabeth B. Rae, 50, became Vice President of Human Resources in October 2005 and has served as Vice President of Worldwide Compensation and Benefits since January 2002. She joined Waters Corporation in January 1996 as Director of Worldwide Compensation. Prior to joining Waters she has held senior human resources positions in retail, healthcare and financial services companies. John Ornell, 50, became Vice President, Finance and Administration and Chief Financial Officer in June 2001. He joined Millipore in 1990 and previously served as Vice President, Operations. During his years at Waters, he has also been Vice President of Manufacturing and Engineering, had responsibility for Operations Finance and Distribution and had a senior role in the successful implementation of the Company’s worldwide business systems. Mark T. Beaudouin, 53, became Vice President, General Counsel and Secretary of the Company in April 2003. Prior to joining Waters, he served as Senior Vice President, General Counsel and Secretary of PAREXEL International Corporation, a bio/pharmaceutical services company, from January 2000 to April 2003. Previously, from May 1985 to January 2000, Mr. Beaudouin served in several senior legal management positions, including Vice President, General Counsel and Secretary of BC International, Inc., a development stage biotechnology company, First Senior Vice President, General Counsel and Secretary of J. Baker, Inc., a diversified retail company, and General Counsel and Secretary of GenRad, Inc., a high technology test equipment manufacturer. Terry Kelly, 45, became President of TA Instruments-Waters LLC in February 2005. He started his career in finance & accounting at ICI in 1985. He joined DuPont in 1988, and held various sales and marketing positions with DuPont, and later TA Instruments. He joined Waters in 1996 when TA Instruments was acquired. |
Ms. Reed, 51, has served as a Director of the Company since May 2006. She is currently Senior Vice President, Finance and Chief Financial Officer of Medco Health Solutions, Inc., a position She assumed in 2002. From 1992 to 2002, Ms. Reed served as Senior Vice President, Finance. She joined Medco Containment Services, Inc. in 1988. Her prior experience includes positions at CBS, Inc., Aetna/American Re-insurance Co., Standard and Poor’s and Unisys/Timeplex. She is a member of the Board of Trustees of St. Mary’s College of Notre Dame.
